Overview of Biomarkers

[1]  E. Taioli,et al.  Human metallothionein gene expression determined by quantitative reverse transcription-polymerase chain reaction as a biomarker of cadmium exposure. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  J. Lay,et al.  Haemoglobin adducts as biomarkers of exposure to the herbicides propanil and fluometuron. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[3]  Y. Nakahara,et al.  Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair. , 1995, Biological & pharmaceutical bulletin.

[4]  M. Neghab,et al.  Serum bile acids as a sensitive biological marker for evaluating hepatic effects of organic solvents , 2000 .

[5]  John A. Timbrell,et al.  Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats , 2005, Archives of Toxicology.

[6]  D W Nebert,et al.  Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. , 1996, DNA and cell biology.

[7]  B. K. Park,et al.  Development of a monoclonal antibody to 6β-hydroxycortisol and its application in an enzyme-linked immunosorbent assay (ELISA) for 6β-hydroxycortisol in urine , 1997 .

[8]  M. Pasanen,et al.  DNA adducts in human placenta as biomarkers for environmental pollution, analysed by the 32P-HPLC method , 2000, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[9]  Williamr．Kelce,et al.  Male reproductive toxicology. , 1991 .

[10]  B. Jönsson,et al.  Haemoglobin adducts and specific immunoglobulin G in humans as biomarkers of exposure to hexahydrophthalic anhydride. , 1997 .

[11]  J. Cocker,et al.  Development and validation of a competitive immunoassay for urinary S-phenylmercapturic acid and its application in benzene biological monitoring , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[12]  G. Keith,et al.  Postlabeling: a sensitive method for studying DNA adducts and their role in carcinogenesis. , 1995, Current opinion in biotechnology.

[13]  R. Tukey,et al.  Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. , 1992, Pharmacogenetics.

[14]  G. Coetzee,et al.  Genetic susceptibility to cancer from exogenous and endogenous exposures , 1996, Journal of cellular biochemistry. Supplement.

[15]  H. Bartsch,et al.  DNA base adducts in urine andwhite blood cells of cancer patients receiving combination chemotherapies which include N-methyl-N-nitrosourea. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[16]  C. Harley,et al.  Metallothionein mRNA and protein induction by cadmium in peripheral-blood leucocytes. , 1989, The Biochemical journal.

[17]  D. Christiani,et al.  Utilization of biomarker data for clinical and environmental intervention. , 1996, Environmental health perspectives.

[18]  C. Waterfield,et al.  Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats. , 2003, Biochimica et biophysica acta.

[19]  F P Perera,et al.  Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. , 2001, Cancer research.

[20]  J. Miners,et al.  The use of caffeine as a metabolic probe for human drug metabolizing enzymes. , 1996, General pharmacology.

[21]  K. Squibb,et al.  Detection of cadmium exposure in rats by induction of lymphocyte metallothionein gene expression. , 1991, Journal of toxicology and environmental health.

[22]  K. Hemminki,et al.  Styrene: from characterisation of DNA adducts to application in styrene-exposed lamination workers. , 1995, Toxicology letters.

[23]  T J Bucci,et al.  Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. , 1991, The American journal of pathology.

[24]  N. Vermeulen,et al.  Mercapturic acids as biomarkers of exposure to electrophilic chemicals: applications to environmental and industrial chemicals. , 1998 .

[25]  J. Celis,et al.  2D protein electrophoresis: can it be perfected? , 1999, Current opinion in biotechnology.

[26]  W. F. Athas,et al.  Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. , 1991, Cancer research.

[27]  N. Vermeulen,et al.  Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. , 1992, Critical reviews in toxicology.

[28]  J. Nicholson,et al.  Hepatotoxin-induced hypertaurinuria: a proton NMR study , 2005, Archives of Toxicology.

[29]  M. Toraason.  8 Hydroxydeoxyguanosine as a biomarker of workplace exposures. , 1999, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[30]  R. Albertini,et al.  Future research directions for evaluating human genetic and cancer risk from environmental exposures. , 1996, Environmental health perspectives.

[31]  Mark Cockerill,et al.  Genomics and the search for novel biomarkers in toxicology , 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[32]  B. Goldstein,et al.  12th meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals: susceptibility to environmental hazards. , 1997, Environmental health perspectives.

[33]  A. Mantovani,et al.  Testicular creatine and urinary creatine-creatinine profiles in mice after the administration of the reproductive toxicant methoxyacetic acid. , 1997 .

[34]  J. Timbrell,et al.  An investigation into the sensitivity of heat shock proteins as markers of cellular damage: a comparative study of hydrazine and cadmium chloride in primary rat hepatocyte cultures. , 1998 .

[35]  I. Wilson,et al.  A proton magnetic resonance study of the metabolism of N-methylformamide in the rat. , 1986, Drug metabolism and disposition: the biological fate of chemicals.

[36]  M. Ikeda,et al.  A simple HPLC method to determine urinary phenylmercapturic acid and its application to gasoline station attendants to biomonitor occupational exposure to benzene at less than 1 ppm , 2001, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[37]  N. Stacey,et al.  Individual serum bile acids as early indicators of carbon tetrachloride- and chloroform-induced liver injury. , 1992, Toxicology.

[38]  P. Turner,et al.  Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. , 1975, British journal of clinical pharmacology.

[39]  J. Bucher,et al.  The influence of cytochrome P450 enzyme activity on the composition and quantity of volatile organics in expired breath. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[40]  P J Sadler,et al.  Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. , 1989, Molecular pharmacology.

[41]  P. Vineis,et al.  Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[42]  L. S. Haug,et al.  2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in human hair as biomarker for dietary exposure , 1999 .

[43]  J. Cadet,et al.  Monitoring urinary excretion of 5-hydroxymethyluracil for assessment of oxidative DNA damage and repair. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[44]  J. A. Bond,et al.  Biomonitoring of 1,3-butadiene and related compounds. , 1996, Environmental health perspectives.

[45]  M. Francaux,et al.  Changes in serum pneumoproteins caused by short-term exposures to nitrogen trichloride in indoor chlorinated swimming pools , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[46]  Bradford G. Stone,et al.  Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men , 1993, Lipids.

[47]  A. Nafziger,et al.  Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. , 2000, Pharmacogenetics.

[48]  J. Pleil,et al.  A review of the USEPA's single breath canister (SBC) method for exhaled volatile organic biomarkers , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[49]  P. Barnes,et al.  Biomarkers of some pulmonary diseases in exhaled breath , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[50]  J. O’Neill,et al.  Elevated HPRT mutation frequencies in aflatoxin-exposed residents of daxin, Qidong county, People's Republic of China. , 1999, Carcinogenesis.

[51]  K. Hemminki,et al.  Measurement of 7-methyl- and 7-(2-hydroxyethyl)-guanine DNA adducts in white blood cells of smokers and non-smokers , 1998 .

[52]  Increase in urinary excretion of 6β-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction , 1999, Archives of Toxicology.

[53]  P. Schulte,et al.  Contribution of biological markers to occupational health. , 1991, American journal of industrial medicine.

[54]  C. Waterfield,et al.  The correlation between urinary and liver taurine levels and between pre-dose urinary taurine and liver damage. , 1993, Toxicology.

[55]  J. Nicholson,et al.  A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study , 2000 .

[56]  K. Hemminki,et al.  32P-postlabelling/HPLC analysis of various styrene-induced DNA adducts in mice , 2001, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[57]  J. Goldstein,et al.  Genetic Polymorphisms in Human Drug Metabolic Enzymes , 1997 .

[58]  F. Kadlubar,et al.  Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. , 1995, Pharmacogenetics.

[59]  P. Vineis.  Use of biomarkers in epidemiology. The example of metabolic susceptibility to cancer. , 1995, Toxicology letters.

[60]  S. Kennedy.  The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[61]  B. K. Park,et al.  Measurement of urinary 6-β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin , 1979, European Journal of Clinical Pharmacology.

[62]  Kimberly Walter,et al.  Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. , 2002, The American journal of pathology.

[63]  H. Mohrenweiser,et al.  Symposium overview: genetic polymorphisms in DNA repair and cancer risk. , 2002, Toxicology and applied pharmacology.

[64]  C. Hermans,et al.  Clara cell protein (CC16): characteristics and potential applications as biomarker of lung toxicity. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[65]  N. Vermeulen,et al.  Evaluation of urinary biomarkers for radical-induced liver damage in rats treated with carbon tetrachloride. , 1998, Toxicology and applied pharmacology.